Company / Interest Expense
BioLife Solutions, Inc. Interest Expense History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$5.0K
FY2019
5-year range
-
FY2016-FY2019
Trend
+0.0%
vs FY2018
Sector context
#41 of 40
Health Care
What the data says
Among 40 Health Care companies, BioLife Solutions, Inc. is in the top -2% for interest expense. Improved from $190,000 to $5,000 over the past 2 years.
Based on SEC 10-K filings.
$5,000 in FY2019 with a 3-year CAGR of -63.2%.
Improved from $190,000 to $5,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -63.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top -2% in Health CareTop -2% of 40This company $5.0K Sector average $332.7M
▼
-100.0% below sector average
Key checks
Key Insights
- 3-year CAGR of -63.2%, indicating a declining trend.
- In FY2019, interest expense increased 0.0% year-over-year.
- Ranks #41 out of 40 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $5.0K | +0.0% |
| FY2018 | $5.0K | -97.4% |
| FY2017 | $190.0K | +90.0% |
| FY2016 | $100.0K | - |
As of FY2019 · SEC 10-K · Updated Feb 28, 2026